References
Miyawaki Y, Suzuki A, Fujita J, Maki A, Okuyama E, Murata M, Takagi A, Murate T, Kunishima S, Sakai M, Okamoto K, Matsushita T, Naoe T, Saito H, Kojima T (2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 366(25):2390–2396. doi:10.1056/NEJMoa1201994
Takagi Y, Kato I, Ando Y, Nakamura Y, Murata M, Takagi A, Murate T, Kojima T (2014) Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation. Thromb Res 134(4):914–917. doi:10.1016/j.thromres.2014.07.040
Kojima T, Takagi A, Murata M, Takagi Y (2015) Antithrombin resistance: a new mechanism of inherited thrombophilia. Rinsho Ketsueki 56(6):632–638
Djordjevic V, Kovac M, Miljic P, Murata M, Takagi A, Pruner I, Francuski D, Kojima T, Radojkovic D (2013) A novel prothrombin mutation in two families with prominent thrombophilia—the first cases of antithrombin resistance in a Caucasian population. J Thromb Haemost 11(10):1936–1939
Sivasundar S, Oommen AT, Prakash O, Baskaran S, Biswas R, Nair S, Mohan CG, Biswas L (2013) Molecular defect of ‘Prothrombin Amrita’: substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin. Blood Cells Mol Dis 50(3):182–183. doi:10.1016/j.bcmd.2012.11.008
Murata M, Takagi A, Suzuki A, Okuyama E, Takagi Y, Ando Y, Kato I, Nakamura Y, Murate T, Matsushita T, Saito H, Kojima T (2014) Development of a new laboratory test to evaluate antithrombin resistance in plasma. Thromb Res 133(2):293–298
Kovac M, Elezovic I, Mikovic Z, Mandic V, Djordjevic V, Radojkovic D, Lalic-Cosic S, Murata M, Takagi A, Kojima T (2015) High prophylactic LMWH dose successfully suppressed hemostatic activation in pregnant woman with a new prothrombin c.1787G>A mutation. Thromb Res 135(2):420–422. doi:10.1016/j.thromres.2014.12.008
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The protocol was performed according to the Declaration of Helsinki and was approved by the ethics committees of Nagoya University and Nagoya Medical Center.
Conflict of interest
The authors declare that they have no competing interests.
Informed consent
Informed consent was obtained from the patient and two family members
Rights and permissions
About this article
Cite this article
Kishimoto, M., Suzuki, N., Murata, M. et al. The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese. Ann Hematol 95, 541–542 (2016). https://doi.org/10.1007/s00277-015-2533-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2533-6